23andMe Lays Off 40% of Staff, Shuts Drug Development Business

The genetics company is closing a unit that was once seen as core to its future.

Read more…

spot_imgspot_img

Latest news

Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here